Advertisement
Screener

NeoGenomics, Inc. (NEO) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax

NeoGenomics, Inc. Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax

NeoGenomics, Inc. (NEO) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-24.

Discontinued › Income Statement › Other Income

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax · last filed 2023-02-24

  • NeoGenomics, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2021-12-31 was $0.00.
  • NeoGenomics, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2021-09-30 was $0.00.
  • NeoGenomics, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
  • NeoGenomics, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for the quarter ending 2021-03-31 was $0.00.
  • NeoGenomics, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2022 was $0.00.
  • NeoGenomics, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2021 was $0.00.
  • NeoGenomics, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2020 was -$1.00M.
  • NeoGenomics, Inc. other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, after tax for fiscal 2019 was -$1.04M.
Period endOther Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 3 monthOther Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 6 monthOther Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 9 monthOther Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax 12 month
2022-12-31$0.00
10-K · filed 2023-02-24
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
$0.00
derived: sum of 2 quarters · filed 2023-02-24
$0.00
derived: sum of 3 quarters · filed 2023-02-24
$0.00
10-K · filed 2023-02-24
2021-09-30$0.00
10-Q · filed 2021-11-04
$0.00
derived: sum of 2 quarters · filed 2021-11-04
$0.00
10-Q · filed 2021-11-04
$0.00
derived: sum of 4 quarters · filed 2023-02-24
2021-06-30$0.00
10-Q · filed 2021-08-09
$0.00
10-Q · filed 2021-08-09
$0.00
derived: sum of 3 quarters · filed 2023-02-24
$0.00
derived: sum of 4 quarters · filed 2023-02-24
2021-03-31$0.00
10-Q · filed 2021-05-06
$0.00
derived: sum of 2 quarters · filed 2023-02-24
$0.00
derived: sum of 3 quarters · filed 2023-02-24
$38.00K
derived: sum of 4 quarters · filed 2023-02-24
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
$0.00
derived: sum of 2 quarters · filed 2023-02-24
$38.00K
derived: sum of 3 quarters · filed 2023-02-24
-$1.00M
10-K · filed 2023-02-24
2020-09-30$0.00
10-Q · filed 2021-11-04
$38.00K
derived: sum of 2 quarters · filed 2021-11-04
-$1.00M
10-Q · filed 2021-11-04
-$238.00K
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$38.00K
10-Q · filed 2021-08-09
-$1.00M
10-Q · filed 2021-08-09
-$238.00K
derived: sum of 3 quarters · filed 2022-02-25
-$455.00K
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31-$1.04M
10-Q · filed 2021-05-06
-$276.00K
derived: sum of 2 quarters · filed 2022-02-25
-$493.00K
derived: sum of 3 quarters · filed 2022-02-25
-$1.52M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$762.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$545.00K
derived: sum of 2 quarters · filed 2022-02-25
-$482.00K
derived: sum of 3 quarters · filed 2022-02-25
-$1.04M
10-K · filed 2022-02-25
2019-09-30-$217.00K
10-Q · filed 2020-10-29
-$1.24M
derived: sum of 2 quarters · filed 2020-10-29
-$1.80M
10-Q · filed 2020-10-29
2019-06-30-$1.03M
10-Q · filed 2020-07-31
-$1.58M
10-Q · filed 2020-07-31
2018-12-31-$785.00K
10-K · filed 2021-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
20/20 Biolabs, Inc. (AIDX)United States$0.005B